Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Other
|
FDA
|
NIAID
|
2019
|
|
Interagency Agreement with the Food and Drug Administration (FDA)
|
Other
|
FDA
|
NIAID
|
2016
|
|